Antibiotic susceptibilities of 94 isolates of Yersinia pestis to 24 antimicrobial agents

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 6, 2003, Pages 1029-1031

  Hernandez, Eric ^a   Girardet, Monique ^a   Ramisse, Francoise ^b   Vidal, Dominique ^c   Cavallo, Jean Didier ^a  

^a SERVICE D ENDOCRINOLOGIE   (France)

^b CENTRE D ETUDES DU BOUCHET   (France)

^c CENTRE DE RECHERCHES   (France)

Author keywords

Antibiotic susceptibility; Plague; Y. pestis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DOXYCYCLINE; GATIFLOXACIN; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DILUTION; NONHUMAN; YERSINIA PESTIS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PLAGUE; YERSINIA PESTIS;

EID: 0346888672     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg484     Document Type: Article

References (10)

1. Butler, T. (1989). The black death past and present. Plague in the 1980s. Transactions of the Royal Society of Tropical Medicine and Hygiene 83, 458-60.
2. Byrne, W. R., Welkos, S. L., Pitt, M. L. et al. (1998). Antibiotic treatment of experimental pneumonic plague in mice. Antimicrobial Agents and Chemotherapy 42, 675-81.
3. Galimand, M., Guiyoule, A., Gerbaud, G. et al. (1997). Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. New England Journal of Medicine 337, 677-80.
4. Guiyoule, A., Gerbaud, G., Buchrieser, C. et al. (2001). Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis. Emerging Infectious Diseases 7, 43-8.
5. Wong, J. D., Barash, J. R., Sandfort, R. F. et al. (2000). Susceptibilities of Yersinia pestis strains to 12 antimicrobial agents. Antimicrobial Agents and Chemotherapy 44, 1995-6.
6. Inglesby, T. V., Dennis, D. T., Henderson, D. A. et al. (2000). Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. Journal of the American Medical Association 283, 2281-90.
7. Motin, V. L., Georgescu, A. M., Elliott, J. M. et al. (2002). Genetic variability of Yersinia pestis isolates as predicted by PCR-based IS100 genotyping and analysis of structural genes encoding glycerol-3-phosphate dehydrogenase (glpD). Journal of Bacteriology 184, 1019-27.
8. Comité de l'Antibiogramme de la Société Française de Microbiologie. (2003). Report 2003. International Journal of Antimicrobial Agents 21, 364-91.
9. Frean, J. A., Arntzen, L., Capper, T. et al. (1996). In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus. Antimicrobial Agents and Chemotherapy 40, 2646-7.
10. Rahalison, L., Guiyoule, A., Bonacorsi, S. P. et al. (2000). Failure of oily chloramphenicol depot injection to treat plague in a murine model. Journal of Antimicrobial Chemotherapy 45, 541-5.